KRAS and colorectal carcinoma: To investigate whether KRAS mutations affect the composition and diversity of the gut microbiota in CRC patients, we performed metagenomic sequencing on fecal samples prospectively collected from CRC patients with KRAS mutations (n = 20) and KRAS WT (n = 20) (Figure S1A and Table S1-S2).